Conor J Kane, Jordan Borgeson, Christie Greason, Jeffrey G Malins, D M Anisuzzaman, Gal Tsaban, Daniel Schonfeld, John I Jackson, Julia Wood, Eunjung Lee, Jwan A Naser, Paul A Friedman, Francisco Lopez-Jimenez, Garvan C Kane, Jae K Oh, Patricia A Pellikka, Timothy J Poterucha, Andrew Rosenbaum, Zachi I Attia, Jeremy J Thaden, Sorin V Pislaru, Jared G Bird
{"title":"智能聚焦:人工智能引导的心脏超声聚焦使新手能够检测左心室功能障碍。","authors":"Conor J Kane, Jordan Borgeson, Christie Greason, Jeffrey G Malins, D M Anisuzzaman, Gal Tsaban, Daniel Schonfeld, John I Jackson, Julia Wood, Eunjung Lee, Jwan A Naser, Paul A Friedman, Francisco Lopez-Jimenez, Garvan C Kane, Jae K Oh, Patricia A Pellikka, Timothy J Poterucha, Andrew Rosenbaum, Zachi I Attia, Jeremy J Thaden, Sorin V Pislaru, Jared G Bird","doi":"10.1093/ehjdh/ztag066","DOIUrl":null,"url":null,"abstract":"<p><strong>Aims: </strong>Heart failure is prevalent; however, there is no cost-effective screening option. Against formal echocardiography, we assessed the diagnostic performance of focused cardiac ultrasound (FoCUS), performed by novice users guided and interpreted by artificial intelligence (AI) for the assessment of left ventricular ejection fraction (LVEF).</p><p><strong>Methods and results: </strong>We prospectively enrolled 496 adults referred for diagnostic echocardiography. Novice operators (without clinical or imaging experience) underwent a 4-h imaging workshop, then performed FoCUS using a point-of-care device (Philips Lumify) utilizing real-time AI-image guidance (UltraSight). Images were assessed by AI-image interpretation software (Mayo Clinic), and two expert blinded echocardiologists. Median age was 67, 39% female, and body mass index range 17-56 kg/m<sup>2</sup>. Forty-one subjects (8.3%) exhibited moderate or greater LV dilatation and 28 (5.6%) had LVEF <40%. The median scan time was 4 min (IQR 3-5). Adequate views were achieved in 95.0% and 97.4% of subjects for AI interpretation and expert analysis, respectively. A two-step diagnostic screening process for low EF in which only abnormal AI reads or uninterpretable scans were reviewed by experts (15.1%) had a sensitivity 96.2%, specificity 95.4%, PPV 54.3%, and NPV 99.8%. A subsequent prospective validation study of 344 subjects demonstrated similar results (sensitivity 100%, specificity 99.4%).</p><p><strong>Conclusion: </strong>In this early feasibility investigation, AI-guidance technology embedded on a handheld device, enabled novice users without clinical or imaging experience to acquire sufficient quality images to accurately assess LVEF with minimal training. The technology evaluated in this study may hold promise for AI-guidance and interpretation to facilitate low-cost screening for cardiac dysfunction.</p>","PeriodicalId":72965,"journal":{"name":"European heart journal. Digital health","volume":"7 5","pages":"ztag066"},"PeriodicalIF":4.4000,"publicationDate":"2026-05-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13188223/pdf/","citationCount":"0","resultStr":"{\"title\":\"Smarter FoCUS: AI-guided focused cardiac ultrasound enables novice detection of left ventricular dysfunction.\",\"authors\":\"Conor J Kane, Jordan Borgeson, Christie Greason, Jeffrey G Malins, D M Anisuzzaman, Gal Tsaban, Daniel Schonfeld, John I Jackson, Julia Wood, Eunjung Lee, Jwan A Naser, Paul A Friedman, Francisco Lopez-Jimenez, Garvan C Kane, Jae K Oh, Patricia A Pellikka, Timothy J Poterucha, Andrew Rosenbaum, Zachi I Attia, Jeremy J Thaden, Sorin V Pislaru, Jared G Bird\",\"doi\":\"10.1093/ehjdh/ztag066\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Aims: </strong>Heart failure is prevalent; however, there is no cost-effective screening option. Against formal echocardiography, we assessed the diagnostic performance of focused cardiac ultrasound (FoCUS), performed by novice users guided and interpreted by artificial intelligence (AI) for the assessment of left ventricular ejection fraction (LVEF).</p><p><strong>Methods and results: </strong>We prospectively enrolled 496 adults referred for diagnostic echocardiography. Novice operators (without clinical or imaging experience) underwent a 4-h imaging workshop, then performed FoCUS using a point-of-care device (Philips Lumify) utilizing real-time AI-image guidance (UltraSight). Images were assessed by AI-image interpretation software (Mayo Clinic), and two expert blinded echocardiologists. Median age was 67, 39% female, and body mass index range 17-56 kg/m<sup>2</sup>. Forty-one subjects (8.3%) exhibited moderate or greater LV dilatation and 28 (5.6%) had LVEF <40%. The median scan time was 4 min (IQR 3-5). Adequate views were achieved in 95.0% and 97.4% of subjects for AI interpretation and expert analysis, respectively. A two-step diagnostic screening process for low EF in which only abnormal AI reads or uninterpretable scans were reviewed by experts (15.1%) had a sensitivity 96.2%, specificity 95.4%, PPV 54.3%, and NPV 99.8%. A subsequent prospective validation study of 344 subjects demonstrated similar results (sensitivity 100%, specificity 99.4%).</p><p><strong>Conclusion: </strong>In this early feasibility investigation, AI-guidance technology embedded on a handheld device, enabled novice users without clinical or imaging experience to acquire sufficient quality images to accurately assess LVEF with minimal training. The technology evaluated in this study may hold promise for AI-guidance and interpretation to facilitate low-cost screening for cardiac dysfunction.</p>\",\"PeriodicalId\":72965,\"journal\":{\"name\":\"European heart journal. Digital health\",\"volume\":\"7 5\",\"pages\":\"ztag066\"},\"PeriodicalIF\":4.4000,\"publicationDate\":\"2026-05-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13188223/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"European heart journal. Digital health\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1093/ehjdh/ztag066\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2026/6/1 0:00:00\",\"PubModel\":\"eCollection\",\"JCR\":\"Q1\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"European heart journal. Digital health","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1093/ehjdh/ztag066","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/6/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
Smarter FoCUS: AI-guided focused cardiac ultrasound enables novice detection of left ventricular dysfunction.
Aims: Heart failure is prevalent; however, there is no cost-effective screening option. Against formal echocardiography, we assessed the diagnostic performance of focused cardiac ultrasound (FoCUS), performed by novice users guided and interpreted by artificial intelligence (AI) for the assessment of left ventricular ejection fraction (LVEF).
Methods and results: We prospectively enrolled 496 adults referred for diagnostic echocardiography. Novice operators (without clinical or imaging experience) underwent a 4-h imaging workshop, then performed FoCUS using a point-of-care device (Philips Lumify) utilizing real-time AI-image guidance (UltraSight). Images were assessed by AI-image interpretation software (Mayo Clinic), and two expert blinded echocardiologists. Median age was 67, 39% female, and body mass index range 17-56 kg/m2. Forty-one subjects (8.3%) exhibited moderate or greater LV dilatation and 28 (5.6%) had LVEF <40%. The median scan time was 4 min (IQR 3-5). Adequate views were achieved in 95.0% and 97.4% of subjects for AI interpretation and expert analysis, respectively. A two-step diagnostic screening process for low EF in which only abnormal AI reads or uninterpretable scans were reviewed by experts (15.1%) had a sensitivity 96.2%, specificity 95.4%, PPV 54.3%, and NPV 99.8%. A subsequent prospective validation study of 344 subjects demonstrated similar results (sensitivity 100%, specificity 99.4%).
Conclusion: In this early feasibility investigation, AI-guidance technology embedded on a handheld device, enabled novice users without clinical or imaging experience to acquire sufficient quality images to accurately assess LVEF with minimal training. The technology evaluated in this study may hold promise for AI-guidance and interpretation to facilitate low-cost screening for cardiac dysfunction.